MX9703720A - Compuestos de 18-nor-vitamina d. - Google Patents
Compuestos de 18-nor-vitamina d.Info
- Publication number
- MX9703720A MX9703720A MX9703720A MX9703720A MX9703720A MX 9703720 A MX9703720 A MX 9703720A MX 9703720 A MX9703720 A MX 9703720A MX 9703720 A MX9703720 A MX 9703720A MX 9703720 A MX9703720 A MX 9703720A
- Authority
- MX
- Mexico
- Prior art keywords
- vitamin
- compounds
- activity
- treatment
- cell differentiation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 229940046008 vitamin d Drugs 0.000 title abstract 2
- 230000000694 effects Effects 0.000 abstract 3
- 230000024245 cell differentiation Effects 0.000 abstract 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 1
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 230000000125 calcaemic effect Effects 0.000 abstract 1
- 229960005084 calcitriol Drugs 0.000 abstract 1
- 229910052791 calcium Inorganic materials 0.000 abstract 1
- 239000011575 calcium Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 230000011164 ossification Effects 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Análogos de 18-nor-vitamina D3 en donde el grupo metilo angular conectado al carbono 13 del anillo CD, se ha retirado y reemplazado por un átomo de hidrogeno. Los compuestos 18-nor-vitamina D se caracterizan por actividad de diferenciacion celular relativamente elevada, mientras que exhiben mucho menor actividad que 1a, 25-dihidroxivitamina D3 en su capacidad por movilizar calcio de huesos. Estos compuestos serían utiles para el tratamiento de enfermedades en donde se desea formacion de huesos, tal como osteoporosis debido a su actividad calcémica preferencial, y para el tratamiento de psoriasis debido a su actividad de diferenciacion celular.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34287094A | 1994-11-21 | 1994-11-21 | |
| US342870 | 1994-11-21 | ||
| PCT/US1995/014732 WO1996016036A1 (en) | 1994-11-21 | 1995-11-13 | 18-nor-vitamin d compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9703720A true MX9703720A (es) | 1997-09-30 |
| MXPA97003720A MXPA97003720A (es) | 1998-07-03 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996016036A1 (en) | 1996-05-30 |
| JPH10509716A (ja) | 1998-09-22 |
| NO972257L (no) | 1997-07-10 |
| US5767111A (en) | 1998-06-16 |
| HUT77669A (hu) | 1998-07-28 |
| CA2206873A1 (en) | 1996-05-30 |
| NO972257D0 (no) | 1997-05-16 |
| EP0793648A1 (en) | 1997-09-10 |
| AU4156796A (en) | 1996-06-17 |
| KR970707090A (ko) | 1997-12-01 |
| NZ296841A (en) | 1998-07-28 |
| US5661140A (en) | 1997-08-26 |
| US5721224A (en) | 1998-02-24 |
| BR9509740A (pt) | 1997-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9509739A (pt) | Compostos 18,19-dinor-vitamina d | |
| AU687674B2 (en) | Method for obtaining ex vivo human progenitor cell expansion | |
| MX9701292A (es) | Compuestos espiro-azabiciclicos utiles en la terapia. | |
| EP0703785A4 (en) | METHODS FOR TREATING MUSCLE DISEASES AND MUSCLE DISORDER | |
| ATE168996T1 (de) | Neues herstellungsverfahren zur 19-nor vitamin-d- verbindungen | |
| AU4181793A (en) | 24-cyclopropane vitamin D derivatives | |
| NZ503638A (en) | Use of tryptophan and analogs as plant growth regulators | |
| EP0550702A4 (en) | Methods for preparation and use of 1-g(a),24-dihydroxy vitamin d 2? | |
| EP0474517A3 (en) | Novel use of 1alpha-hydroxylated-19-nor-vitamin d compounds to treat psoriasis | |
| IE891406L (en) | Compounds effective in inducing cell differentiation and¹process for preparing same | |
| AU8086494A (en) | 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds | |
| EP0956033A4 (en) | TOTAL SYNTHESIS OF DIDEMNINE A AMINO-HIP ANALOGS | |
| EP1656157A4 (en) | 2-METHYLENE-19-NOR-VITAMIN D2 COMPOUNDS | |
| EP0549318A3 (en) | 26,27-dimethylene-1 alpha, 25-dihydroxyvitamin d2 and 26,27-dihydroxyvitamin d2 and methods for preparing same | |
| ES8700232A1 (es) | Un procedimiento para producir 1a,25-dihidroxi-26,27-dime- tilcolecalciferol | |
| AU1486497A (en) | 1alpha,24(S)-dihydroxy vitamin D2, its formation and use | |
| HU9902668D0 (en) | Compounds with growth hormone releasing properties | |
| NZ535843A (en) | Use of carbon-2-modified-19-nor-vitamin D analogs to induce the formation of new bone | |
| MX9703720A (es) | Compuestos de 18-nor-vitamina d. | |
| MX9803966A (es) | 25-hidroxi-16-en-26,27-bishomo-colecalciferoles. | |
| WO2000010548A3 (en) | 19-nor-vitamin d3 compounds with calcemic activity | |
| EG19338A (en) | Process for preparing of alkylphosphoric acid compounds for combatting psoriasis disorders | |
| ES8308562A1 (es) | Procedimiento para preparar 3',4',5'-trimetoxibenzoato de 1718-dehidorapovincaminol, util como agente activo en preparaciones farmaceuticas | |
| AP2000002004A0 (en) | Method of treatment for dermatological disorders and compositions therefor. | |
| ES2099031A1 (es) | Nuevos polimorfos de diclorhidrato de lesopitron y sus formas hidratadas, procedimientos de preparacion y composiciones que los contienen. |